Showing results (91-100 of 122) with videos related to
Sort By:
Pageof 13
Journal of the American College of Cardiology|March 29, 2020
Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization TherapyPetra Nijst, Pieter Martens, Jeroen Dauw, et al.Journal of the American College of Cardiology|October 29, 2013
Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support)Guilherme H Oliveira, Matthias Dupont, David Naftel, et al.Journal of Cardiac Failure|November 13, 2012
Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodelingFrederik H Verbrugge, Matthias Dupont, Maximo Rivero-Ayerza, et al.JACC. Cardiovascular Interventions|November 9, 2024
Coronary Sinus Narrowing for Treating Refractory Angina: REDUCER-I Multicenter "Real-World" Observational Study Primary Endpoint AnalysisStefan Verheye, Tim P van de Hoef, Ranil de Silva, et al.European Journal of Heart Failure|February 28, 2025
Urinary sodium analysis: The key to effective diuretic titration? European Journal of Heart Failure expert consensus documentEvelyne Meekers, Jeroen Dauw, Jozine M Ter Maaten, et al.European Journal of Heart Failure|August 14, 2024
Nurse-led diuretic titration via a point-of-care urinary sodium sensor in patients with acute decompensated heart failure (EASY-HF): A single-centre, randomized, open-label studyEvelyne Meekers, Pieter Martens, Jeroen Dauw, et al.European Journal of Heart Failure|October 31, 2023
Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysisSander Trenson, Gabor Voros, Pieter Martens, et al.Acta Cardiologica|November 5, 2025
Optimisation of heart failure management: insights into GDMT and loop diuretic utilisation in a specialised heart failure clinicEvelyne Meekers, Zara Arcidiacono, Romy Baptist, et al.European Journal of Heart Failure|September 22, 2018
Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trialWilfried Mullens, Frederik H Verbrugge, Petra Nijst, et al.ESC Heart Failure|July 30, 2025
Patient-specific modifiers of survival benefit in cardiac resynchronization therapy - A multicentre interaction analysisBert Vandenberk, Marius Brusselmans, Gabor Voros, et al.Pageof 13